Page 113 - Bladder Dysfunction in the Context of the Bladder-Brain Connection - Ilse Groenendijk.pdf
P. 113
Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters
111
REFERENCES
1. Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol. 2006;175(3 Pt 2):S5-10.
2. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760-766.
3. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306-1314; discussion 1314-1305.
4. Digesu GA, Khullar V, Cardozo L, Salvatore S. Overactive bladder symptoms: do we need urody- namics? Neurourol Urodyn. 2003;22(2):105-108.
5. Buckhard F, Biosch J, Cruz F, et al. EAU Guidelines on Urinary Incontinence in Adults. 2019.
6. Siegel S, Noblett K, Mangel J, et al. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation. J Urol. 2018;199(1):229-
236.
7. Blok BF, Groen J, Bosch JL, Veltman DJ, Lammertsma AA. Different brain effects during chronic
and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators.
BJU Int. 2006;98(6):1238-1243.
8. Cadish LA, Osann KE, Noblett KL. Stimulation latency and comparison of cycling regimens in
women using sacral neuromodulation. Neurourol Urodyn. 2017;36(2):486-489.
9. Altomare DF, Ratto C, Ganio E, Lolli P, Masin A, Villani RD. Long-term outcome of sacral nerve
stimulation for fecal incontinence. Dis Colon Rectum. 2009;52(1):11-17.
10. Agnew WF, McCreery DB, Yuen TG, Bullara LA. Evolution and resolution of stimulation-induced
axonal injury in peripheral nerve. Muscle Nerve. 1999;22(10):1393-1402.
11. ‘t Hoen LA, Groen J, Scheepe JR, Blok BF. Intermittent sacral neuromodulation for idiopathic
urgency urinary incontinence in women. Neurourol Urodyn. 2017;36(2):385-389.
12. Blok B, Van Kerrebroeck P, de Wachter S, et al. Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overac-
tive bladder. Neurourol Urodyn. 2018;37(S2):S17-S22.
13. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of sacral neuromodulation
therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J
Urol. 2007;178(5):2029-2034.
14. Oerlemans DJ, van Voskuilen AC, Marcelissen T, Weil EH, de Bie RA, Van Kerrebroeck PE. Is on-
demand sacral neuromodulation in patients with OAB syndrome a feasible therapy regime?
Neurourol Urodyn. 2011;30(8):1493-1496.
15. Groen J, Blok BF, Bosch JL. Sacral neuromodulation as treatment for refractory idiopathic urge
urinary incontinence: 5-year results of a longitudinal study in 60 women. J Urol. 2011;186(3):954-
959.
16. Chen SC, Hsieh TH, Fan WJ, et al. Design and evaluation of potentiometric principles for bladder
volume monitoring: a preliminary study. Sensors (Basel). 2015;15(6):12802-12815.
17. Seif C, Herberger B, Cherwon E, et al. Urinary bladder volumetry by means of a single retrosym-
physically implantable ultrasound unit. Neurourol Urodyn. 2004;23(7):680-684.
18. Ouyang Z, Sperry ZJ, Barrera ND, Bruns TM. Real-time Bladder Pressure Estimation for Closed-loop
Control in a Detrusor Overactivity Model. IEEE Trans Neural Syst Rehabil Eng. 2019.
5